Identification of Treg-related prognostic molecular subtypes and individualized characteristics in clear cell renal cell carcinoma through single-cell transcriptomes and bulk RNA sequencing
- 4 March 2024
- journal article
- research article
- Published by Elsevier in International Immunopharmacology
- Vol. 130, 111746
Abstract
No abstract availableKeywords
Funding Information
- Natural Science Foundation of Guangdong Province (2019A1515012116)
This publication has 53 references indexed in Scilit:
- Can Molecular Classifications Help Tailor First-line Treatment of Metastatic Renal Cell Carcinoma? A Systematic Review of Available ModelsEuropean Urology Open Science, 2022
- Activation of B cells in Tertiary Lymphoid Structures in cancer: Anti-tumor or anti-self?Seminars in Immunology, 2022
- Tumor metabolite lactate promotes tumorigenesis by modulating MOESIN lactylation and enhancing TGF-β signaling in regulatory T cellsCell Reports, 2022
- Immunotherapy of Cancer by Targeting Regulatory T cellsInternational Immunopharmacology, 2022
- Tumor necrosis factor receptor family costimulation increases regulatory T‐cell activation and function via NF‐κBEuropean Journal of Immunology, 2020
- Human FOXP3+ Regulatory T Cell Heterogeneity and Function in Autoimmunity and CancerImmunity, 2019
- Current and emerging therapies for first-line treatment of metastatic clear cell renal cell carcinomaCancer Treatment Reviews, 2018
- Continuous T Cell Receptor Signals Maintain a Functional Regulatory T Cell PoolImmunity, 2014
- Tertiary lymphoid structures in cancer and beyondTrends in Immunology, 2014
- Functional Delineation and Differentiation Dynamics of Human CD4+ T Cells Expressing the FoxP3 Transcription FactorImmunity, 2009